tiprankstipranks
Trending News
More News >
Intervacc AB (DE:2E9)
FRANKFURT:2E9

Compare Intervacc AB (2E9) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intervacc AB
€0.05
€28.95M
-1.08
50.00%
Xbrane Biopharma AB
kr10.37
kr249.94M
1.35
-40.47%
Elicera Therapeutics AB
kr5.35
kr287.33M
-17.23
181.90%
Ascelia Pharma AB
kr3.17
kr396.46M
-3.64
15.31%
IRLAB Therapeutics AB Class A
kr2.01
kr169.88M
-1.27
-79.73%
Immunicum AB
kr5.77
kr346.23M
-2.83
-29.15%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2E9
Intervacc AB
0.04
>-0.01
-12.20%
SE:XBRANE
Xbrane Biopharma AB
12.13
-7.49
-38.19%
SE:ELIC
Elicera Therapeutics AB
5.92
3.60
155.17%
SE:ACE
Ascelia Pharma AB
3.13
0.21
7.20%
SE:IRLAB.A
IRLAB Therapeutics AB Class A
2.00
-6.78
-77.22%
SE:IMMU
Immunicum AB
5.81
-2.41
-29.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts